Pharmaceutical dosage forms comprising a low-solubility drug and a polymer

Details for Australian Patent Application No. 2005278894 (hide)

Owner Pfizer Products Inc.

Inventors Babcock, Walter Christian; Smithey, Daniel Tod; Shamblin, Sheri Lynn; Friesen, Dwayne Thomas; Appel, Leah Elizabeth; Shanker, Ravi Mysore; Ray, Roderick Jack

Agent Spruson & Ferguson

Pub. Number AU-A-2005278894

PCT Pub. Number WO2006/024944

Priority 60/606,178 31.08.04 US

Filing date 18 August 2005

Wipo publication date 9 March 2006

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/024944 Priority application(s): WO2006/024944

26 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005278896-Improvements relating to meningococcal outer membrane vesicles

2005278892-Androgen modulators